Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
John H Tucker Insider Profile
4 Followers
John H Tucker, President & CEO, Director at scPharmaceuticals, holds 254.21K shares in scPharmaceuticals (Ticker: SCPH).
John H Tucker scPharmaceuticals (SCPH)President & CEO, Director
scPharmaceuticals (SCPH)
President & CEO, Director
Ranked #32,769 out of 100,202 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+39.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that John H Tucker holds in companies
Most Profitable Insider Trade
The most profitable trade made by John H Tucker
John H Tucker's Trading History
List of latest transactions for each holding click on a transaction to see John H Tucker's performance on stock
You May Also Like
John H Tucker insider profile FAQ
What is the percentage of profitable transactions made by John H Tucker?
The percentage of profitable transactions made by John H Tucker is 100%.
What is the average return per transaction made by John H Tucker?
The average return per transaction made by John H Tucker is 39.60%.
What stocks does John H Tucker hold?
John H Tucker holds: SCPH stocks.
What was John H Tucker’s latest transaction?
John H Tucker latest transaction was an Uninformative Buy of ―.
What was John H Tucker's most profitable transaction?
John H Tucker’s most profitable transaction was an Informative Buy of SCPH stock on December 6, 2021. The return on the trade was 62.60%.
What is John H Tucker's role in scPharmaceuticals?
John H Tucker's role in scPharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.